Heraeus Medical, Inc.
Heraeus Medical, Inc., a prominent player in the medical technology industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1851, the company has established itself as a leader in the development of innovative biomaterials and medical devices, particularly in orthopaedics and trauma care. Heraeus Medical is renowned for its core products, including bone cements and surgical solutions, which are distinguished by their superior quality and performance. The company’s commitment to research and development has led to significant advancements in patient care, solidifying its market position as a trusted provider in the healthcare sector. With a rich history and a focus on enhancing surgical outcomes, Heraeus Medical continues to set benchmarks in the medical field.
DitchCarbon Score
How does Heraeus Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Electrical Machinery Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Heraeus Medical, Inc.'s score of 28 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Heraeus Medical, Inc.'s reported carbon emissions
In 2023, Heraeus Medical, Inc. reported a total of approximately 1,706,000 kg CO2e in carbon emissions, comprising 645,000 kg CO2e from Scope 1 and 1,063,000 kg CO2e from Scope 2 emissions. Notably, there was a significant reduction in Scope 1 emissions from 814,000 kg CO2e in 2021 to 645,000 kg CO2e in 2023, indicating a proactive approach to minimising direct emissions. However, Scope 2 emissions remained consistent with a slight increase from 1,014,000 kg CO2e in 2021 to 1,063,000 kg CO2e in 2022, before stabilising in 2023. Heraeus Medical has not disclosed specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The company’s commitment to reducing its carbon footprint is evident through its ongoing efforts to manage and report emissions across all relevant scopes. As the industry increasingly focuses on sustainability, Heraeus Medical's emissions data reflects a growing awareness and responsibility towards climate impact, although further commitments and targets would enhance their climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 814,000 | 000,000 | 000,000 |
| Scope 2 | 1,014,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 14,798,310 | 00.0 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Heraeus Medical, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
